HeimLLY • NYSE
add
Eli Lilly And Co
Við síðustu lokun
906,86 $
Dagbil
883,64 $ - 942,50 $
Árabil
623,78 $ - 942,50 $
Markaðsvirði
881,32 ma. USD
Meðalmagn
3,58 m.
V/H-hlutf.
46,03
A/V-hlutfall
0,64%
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 17,60 ma. | 53,87% |
Rekstrarkostnaður | 6,09 ma. | 29,12% |
Nettótekjur | 5,58 ma. | 475,34% |
Hagnaðarhlutfall | 31,72 | 274,06% |
Hagnaður á hvern hlut | 7,02 | 494,92% |
EBITDA | 8,97 ma. | 78,81% |
Virkt skatthlutfall | 22,81% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 9,91 ma. | 181,76% |
Heildareignir | 114,94 ma. | 52,02% |
Heildarskuldir | 91,08 ma. | 48,62% |
Eigið fé alls | 23,85 ma. | — |
Útistandandi hlutabréf | 895,38 m. | — |
Eiginfjárgengi | 34,14 | — |
Arðsemi eigna | 19,69% | — |
Ávöxtun eigin fjár | 34,07% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 5,58 ma. | 475,34% |
Handbært fé frá rekstri | 8,84 ma. | 138,04% |
Reiðufé frá fjárfestingum | -2,98 ma. | 25,52% |
Reiðufé frá fjármögnun | 531,00 m. | 151,30% |
Breyting á handbæru fé | 6,42 ma. | 4.312,65% |
Frjálst peningaflæði | 2,22 ma. | 256,60% |
Um
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 11th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. Wikipedia
Framkvæmdastjóri
Stofnsett
1876
Höfuðstöðvar
Vefsvæði
Starfsfólk
47.000
